Novus Therapeutics Inc. raised $8.5 million via the sale of 2,463,966 shares of the company.
Irvine, Calif.-based Novus Therapeutics is a pharmaceutical company focused on the development of ear, nose and throat products.
The company was previously known as Tokai Pharmaceuticals Inc.
